MARKER THERAPEUTICS, INC. Proceeds from Notes Payable
MARKER THERAPEUTICS, INC. (MRKR) reported Proceeds from Notes Payable of $52.94 thousand for the 155-month period ending 2012-06-30, per its 10-Q/A filed 2012-09-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2012-09-12
| Period end | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 155 month |
|---|---|---|---|
| 2012-06-30 | $52.94K 10-Q/A · filed 2012-09-12 | $52.94K 10-Q/A · filed 2012-09-12 | |
| 2011-12-31 | $100.00K 10-Q/A · filed 2012-09-12 | ||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |